Smart Cells Releases 1st Sample to Treat Autism
Published: 2018/03/28
Author: Smart Cells - Contact: smartcells.com
Peer-Reviewed: N/A
Related Papers: Latest Items - Full List
On This Page: Summary - Main Article - About/Author
Synopsis: Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Main Digest
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
advertisement
Autism Spectrum Disorder, more commonly known as simply "autism", is a group of developmental brain disorders that affects around 700,000 people in the UK. It affects a person's ability to read body language, understand facial expressions and communicate effectively, and also can cause repetitive, sometimes harmful, behaviour. It is currently incurable but has previously only been treatable through therapy and interventions.
In a breakthrough for stem cell science and the treatment of autism, Smart Cells has released their first sample to infuse in a 5 year old boy with autism at Duke University, North Carolina, USA in March 2018.
With this release, they celebrate their 20th successful sample to be released to a customer from whom cord blood and tissue was collected at birth, closely following the release of a sample that was recently sent to a 3 year old girl at Duke University for a cerebral palsy treatment.
Previous studies have shown that not only are the infusions safe and feasible, which is a hugely important first step in cord blood transplants, but that recipients of the transfusion have also shown improvements in the condition of autism, with reductions in symptoms such as repetitive behaviour and improvements in their general behaviour. The parents and researchers at Duke University noted behavioural improvements in 70% of the 25 children in the study.
The rationale behind using stem cells as treatment is that it can decrease inflammation that is a consistent finding in the brain and gut of people with autism, in turn helping to alleviate their symptoms.
In order to help parents who have children with autism to find support and understand the condition of autism, Smart Cells have released a simple guide to autism that breaks down the facts and stats, explains where parents can turn to find help and what treatments are currently available.
Dr. Ann Smith, Scientific Director at Smart Cells, commented:
"It's a huge breakthrough in the science of autism for us to release our first sample to treat the condition. There are currently further ongoing studies into using stem cells in the treatment of autism, and we expect to see even more promising and positive results in future."
"We hope that by showing our support for World Autism Day with our simple Parents' Guide to Autism, we'll also be able to help parents who don't currently have access to this kind of medical treatment, instead guiding them to find support where they can."
Attribution/Source(s):
This quality-reviewed article relating to our Regenerative Medicine section was selected for publishing by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "Smart Cells Releases 1st Sample to Treat Autism" was originally written by Smart Cells, and published by Disabled-World.com on 2018/03/28. Should you require further information or clarification, Smart Cells can be contacted at smartcells.com. Disabled World makes no warranties or representations in connection therewith.
Share This Information To:
𝕏.com Facebook Reddit
Discover Related Topics:
advertisement
Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page. Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.Information, Citing and Disclaimer
Permalink: <a href="https://www.disabled-world.com/news/research/stemcells/smartcells.php">Smart Cells Releases 1st Sample to Treat Autism</a>
Cite This Page (APA): Smart Cells. (2018, March 28). Smart Cells Releases 1st Sample to Treat Autism. Disabled World. Retrieved September 28, 2023 from www.disabled-world.com/news/research/stemcells/smartcells.php